
Bellicum Pharmaceuticals BLCM
Quarterly report 2023-Q3
added 11-14-2023
Bellicum Pharmaceuticals DPO Ratio 2011-2025 | BLCM
Quarterly DPO Ratio Bellicum Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39 K | 9.76 K | - | 2.48 K | 2.3 K | 10.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 K | 1.39 K | 5.33 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 25.33 | -2.2 % | $ 1.23 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.71 | 0.86 % | $ 782 M | ||
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.31 | -1.64 % | $ 256 M | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 1.3 | -2.26 % | $ 7.09 M | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.53 | 0.42 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.32 | 1.75 % | $ 14.6 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
AstraZeneca PLC
AZN
|
265 | $ 89.4 | -0.99 % | $ 96.9 B | ||
|
Baudax Bio
BXRX
|
140 | - | 0.59 % | $ 63 K | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
90.1 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
29.9 | $ 570.03 | -1.89 % | $ 43.2 B | ||
|
Caladrius Biosciences
CLBS
|
51.2 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
236 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
65.4 | $ 173.43 | 0.54 % | $ 25.3 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
2.2 K | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.38 | -0.52 % | $ 736 M | ||
|
Benitec Biopharma
BNTC
|
-556 | $ 12.27 | -5.32 % | $ 505 M | ||
|
Epizyme
EPZM
|
355 | - | - | $ 249 M | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 14.5 | -5.29 % | $ 955 M | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Cerus Corporation
CERS
|
242 | $ 2.13 | -0.7 % | $ 393 M |